Annika Soderbergh
Overview
Explore the profile of Annika Soderbergh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
113
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lindberg H, Knight A, Hellbacher E, Norling O, Berglin E, Stegmayr B, et al.
ACR Open Rheumatol
. 2025 Mar;
7(3):e70009.
PMID: 40033657
Objective: The antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides are heterogeneous disorders. The aim of this study was to identify and characterize subgroups of patients based on sex, ANCA, age at diagnosis,...
2.
Bejerot S, Hietala A, Soderbergh A, Humble M
Mol Psychiatry
. 2025 Jan;
PMID: 39753888
No abstract available.
3.
Dubovyk V, Vasileiadis G, Fatima T, Zhang Y, Kapetanovic M, Kastbom A, et al.
RMD Open
. 2024 Apr;
10(2).
PMID: 38580350
Objective: This report from the NORD-STAR (Nordic Rheumatic Diseases Strategy Trials and Registries) trial aimed to determine if obesity is associated with response to conventional and biological antirheumatic treatment in...
4.
Bejerot S, Eklund D, Hesser H, Hietala M, Kariis T, Lange N, et al.
BMC Psychiatry
. 2023 Oct;
23(1):771.
PMID: 37872497
Background: The role of inflammation in the aetiology of schizophrenia has gained wide attention and research on the association shows an exponential growth in the last 15 years. Autoimmune diseases...
5.
Ostergaard M, van Vollenhoven R, Rudin A, Hetland M, Heiberg M, Nordstrom D, et al.
Ann Rheum Dis
. 2023 Jul;
82(10):1286-1295.
PMID: 37423647
Background: The optimal first-line treatment in early rheumatoid arthritis (RA) is debated. We compared clinical and radiographic outcomes of active conventional therapy with each of three biological treatments with different...
6.
Ekman D, Sennblad B, Knight A, Karlsson A, Rantapaa-Dahlqvist S, Berglin E, et al.
Rheumatology (Oxford)
. 2023 Apr;
62(9):3213-3218.
PMID: 37004177
Objective: To identify and genetically characterize subgroups of patients with ANCA-associated vasculitides (AAV) based on sex and ANCA subtype. Methods: A previously established SNP dataset derived from DNA sequencing of...
7.
Dahlqvist J, Ekman D, Sennblad B, Kozyrev S, Nordin J, Karlsson A, et al.
Rheumatology (Oxford)
. 2021 Dec;
61(8):3461-3470.
PMID: 34888651
Objective: To identify and characterize genetic loci associated with the risk of developing ANCA-associated vasculitides (AAV). Methods: Genetic association analyses were performed after Illumina sequencing of 1853 genes and subsequent...
8.
Hetland M, Haavardsholm E, Rudin A, Nordstrom D, Nurmohamed M, Gudbjornsson B, et al.
BMJ
. 2020 Dec;
371:m4328.
PMID: 33268527
Objective: To evaluate and compare benefits and harms of three biological treatments with different modes of action versus active conventional treatment in patients with early rheumatoid arthritis. Design: Investigator initiated,...
9.
Soderbergh A, Gustafsson J, Ekwall O, Hallgren A, Nilsson T, Kampe O, et al.
Acta Paediatr
. 2006 Nov;
95(12):1657-60.
PMID: 17129978
Background: Patients with Down syndrome are prone to autoimmune diseases which also occur in the recessive disease autoimmune polyendocrine syndrome type I (APS I). Since this disease is caused by...
10.
Selden A, Berg N, Soderbergh A, Bergstrom B
Occup Med (Lond)
. 2005 Mar;
55(2):145-8.
PMID: 15757993
Background: Molybdenum is an essential trace element and a component of xanthine oxidase, which catalyses the formation of urate. The toxicity of molybdenum in humans is considered to be low,...